Mark Earl Hensley
Chief Operating Officer · HERON THERAPEUTICS, INC. /DE/
- 2026
- Aug 10, 2026
- 5
Summary
Latest filing:
Mark Earl Hensley is Chief Operating Officer of HERON THERAPEUTICS, INC. /DE/ (HRTX). 5 SEC Form 4 filings on record, most recently on 10 August 2026.
Recent transactions
5The latest 5 SEC Form 4 transactions reported by Mark Earl Hensley.
Trading pattern
InsiderAlpha's records for Mark Earl Hensley go back to 2026: 5 primary Form 4 filings, an average of 5.0 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
Other insiders active in the same stocks
Insiders who have reported open-market trades at the same companies as Mark Earl Hensley. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Rubric Capital Management LP - $5.00M in HRTX purchases and sales on record
- Adam Morgan - $3.70M in HRTX purchases and sales on record
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Mark Earl Hensley?
Mark Earl Hensley is a corporate insider, tracked as Chief Operating Officer of HERON THERAPEUTICS, INC. /DE/ (HRTX). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Mark Earl Hensley submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.